Search results
Results from the WOW.Com Content Network
And if you have frequent nosebleeds, you should schedule an appointment with an ear, nose and throat doctor (ENT/otolaryngologist) to figure out the root cause and come up with an appropriate ...
Treatment of atrophic rhinitis can be either medical or surgical. Medical measures include: Nasal irrigation using normal saline [4] Nasal irrigation and removal of crusts using alkaline nasal solutions. 25% glucose in glycerine can be applied to the nasal mucosa to inhibit the growth of proteolytic organisms which produce foul smell.
Sign in. Mail. 24/7 Help. ... This is definitely something a rhinologist should be consulted about–you would need surgery to repair this type of connection, ... OTC treatments can also be useful ...
Here are 10 bizarre allergy treatments throughout history. ... In 1883, E. Schmiegelow, a rhinologist (ear, nose and throat specialist) from Copenhagen, visited a colleague who claimed to cure hay ...
Lhermitte's sign may also appear during or following high-dose chemotherapy. [7] [8] Irradiation of the cervical spine may also evoke it as an early delayed radiation injury, which occurs within 4 months of radiation therapy. [citation needed] Delayed onset Lhermitte's sign has been reported following head and/or neck trauma.
Treatments of the common cold primarily involve medications and other therapies for symptomatic relief. [13] Getting plenty of rest, drinking fluids to maintain hydration, and gargling with warm salt water are reasonable conservative measures. [56] Much of the benefit from symptomatic treatment is, however, attributed to the placebo effect. [57]
Treatment consists of antihistamine, mast cell stabilizers, dual mechanism anti-allergen agents, or topical antihistamines. [2] Corticosteroids are another option, but, considering the side-effects of cataracts and increased intraocular pressure , corticosteroids are reserved for more severe forms of allergic conjunctivitis such as vernal ...
What’s more, RSV vaccines are now available for infants at high risk of severe disease, pregnant women from 32–36 gestational weeks, and adults 60 years of age and older.